Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
Crossref DOI link: https://doi.org/10.1186/s12913-015-0681-y
Published Online: 2015-01-22
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kikuchi, Kayoko
Miyakawa, Yoshitaka
Ikeda, Shunya
Sato, Yuji
Takebayashi, Toru
License valid from 2015-01-22
Article History
Received: 21 February 2014
Accepted: 6 January 2015
First Online: 22 January 2015